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In the present study, we determined the effects of oral administration of L- and D-aspartate (L-Asp and D-Asp)
on food intake over a period of 2 h after the administration, as well as its effects on the concentration of L- and D-Asp
in the brain and plasma. Chicks were orally administered different levels (0, 3.75, 7.5 and 15 mmol/kg body weight)
of L-Asp (Experiment 1) and D-Asp (Experiment 2). Administration of several doses of L-Asp linearly increased the
concentration of L-Asp, but not of D-Asp, in plasma. Oral L-Asp somewhat modified the levels of L- and D-Asp
levels in the telencephalon, but not in the diencephalon. However, food intake was not significantly changed with
doses of L-Asp. On the other hand, D-Asp strongly and dose-dependently inhibited food intake over a period of 2 h
after the administration. Oral D-Asp clearly increased D-Asp levels in the plasma and diencephalon, but no
significant changes in L-Asp were detected. Brain monoamine contents were only minimally influenced by L- or D-
Asp administration. We conclude that D-Asp may act as an anorexigenic factor in the diencephalon.
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Introduction
Glutamate is the major excitatory neurotransmitter in the
central nervous system (CNS) and mediates its action via the
activation of several subtypes of excitatory amino acid
(EAA) receptors including the N-methyl-D-aspartate gluta-
mate (NMDA) receptor (Kubrusly et al., 1998). Past studies
have determined the brain neurochemical systems that
regulate food intake, and have identified a number of
neurotransmitters that appear to contribute to this behavior.
For example, L-aspartate (L-Asp) and its enantiomer D-
aspartate (D-Asp) are EAA members, and have been well
documented as regulators of the endocrine system (Estienne
et al., 1997; D’Aniello et al., 2000a,b); as such, they may
affect the growth performance of domestic animals.
D-Asp, synthesized from L-Asp by aspartate racemase,
can directly stimulate the NMDA receptor (D’Aniello et al.,
2000a; Woloskor et al., 2000). Additionally, numerous
studies involving pharmacological treatments have investi-
gated the role of glutamate in the regulation of appetitive
behavior in mammals. Intracerebroventricular (i.c.v.) ad-
ministration or local administration of glutamate (Reddy et
al., 1986; Ritter and Stone, 1987; Wandji et al., 1989) or the
glutamate agonist, NMDA, induced hyperphagia, but these
effects were not elicited by the administration of kainate or
alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate
(AMPA) in chicks (Bungo et al., 2011). These orexigenic
effects of glutamate and NMDA appear to be mediated not
only by NMDA receptors but also by other EAA receptor
subtypes (Da Silva et al., 2003). Although these reports
suggest that L-Asp and D-Asp might also have an orexigenic
effect in chicks through the activation of the NMDA receptor
in the brain, Bungo et al. (2002) demonstrated that i. c.v.
injection of L-Asp as a glutamate receptor agonist did not
alter eating behaviors in chicks. In addition, numerous
studies have also investigated the role of D-Asp in the
regulation of food intake in mammals. For instance,
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Koyuncuoğlu et al. (1982) reported that orally administered
D-Asp caused significant decreases in body weight and the
weight of the liver, as well as in daily food intake in rats. As
with mammals, it was reported that D-Asp in the diet reduced
food intake in chicks (Maruyama et al., 1972). In fact, L-
and D-Asp have been shown to exist in various brain regions
of the chicken (Neidle and Dunlop, 1990) and the pigeon
(Kera et al., 1996). However, little is known about the
mechanisms underlying the effects of either L- or D-Asp on
food intake in chicks. The purpose of the present study was
to examine the effects of the oral administration of different
doses of L- and D-Asp on food intake in chicks. We ex-
plored this issue further by also investigating the effects of
these treatments on the concentration of L- and D-Asp in
plasma and the brain. The effects of L-Asp and D-Asp on
levels of brain monoamines (dopamine [DA], serotonin [5-
HT] and their metabolites) were also investigated, since these
monoamines have been recognized as regulators of behavior
and/or of stress responses in chicks (Zhang et al., 2003; Saito
et al., 2004; Hamasu et al., 2009).
Materials and Methods
Animals and Drugs
One-day-old layer chicks were purchased from a local
hatchery (Murata hatchery, Fukuoka, Japan) and housed in a
wire-meshed cage (50×35×33 cm) in a group (20-25 birds)
at a constant temperature of 30±1℃ and with continuous
light until the day of the experiment. Chicks were all of the
same age and were housed without an adult. Food (AX,
Toyohashi Feed and Mills Co. Ltd., Aichi, Japan) and water
were available ad libitum. One day before the experiment,
chicks (4 days old) were reared individually and assigned to
treatment groups on the basis of their body weight in order to
produce uniform treatment groups. The number of animals
used in each group was kept to the minimum (n＝8) that
would still ensure adequate statistical power. This study was
performed in accordance with the guidelines for animal
experiments carried out in the Faculty of Agriculture and in
the Graduate Course of Kyushu University, and adhered to
Law no. 105 and Notification no. 6 of the government.
L- and D-Asp were purchased from Wako Pure Chemical
Industries (Osaka, Japan).
Procedure for Oral Administration Test
Following a habituation period, chicks were randomly
selected and divided into four groups each consisting of 8
chicks. The birds were reared individually in experimental
cages and had ad libitum access to diet up to the time of the
experiments. On the day of the experiment, each chick (5
days old) was orally administered distilled water or L-Asp
(Experiment 1) / D-Asp (Experiment 2) solutions by the
elastic plastic needle on small syringe. Finkelstein et al.
(1983) determined plasma L-Asp concentration at 0, 15, 30,
45, 60, and 120min after applying L-Asp at 0, 1.88, 3.76,
4.89, 5.64 and 7.52mmol/kg body weight. Plasma L-Asp
concentration was hardly influenced by 1.88 and 3.76
mmol/kg. Thus, we applied here 3.75, 7.5 and 15.0mmol/kg
of L-Asp and D-Asp as the lowest, medium and highest
levels, respectively.
The birds were fed ad libitum diets for 2 h immediately
after the treatment. Food intake (at 30, 60 and 120min) was
determined by measuring the reduction in the amount of food
consumed from a pre-weighed feeder. The weight of the
feeder was measured using an electric digital balance. At the
end of the experiments, birds were decapitated following
anesthesia with isoflurane (Mylan Inc., Japan). Blood sam-
ples were collected in heparinized tubes and centrifuged for 4
min at 4℃ at 10,000 g, and the plasma was collected and
stored at −80℃ until analysis took place.
Analysis of Monoamines in the Brain
In Experiments 1 and 2, the brains were carefully taken
from the skulls and placed on a cold glass dish. We collected
the brain samples on the glass dish which was kept on dry
ice. Two parts (the telencephalon and the diencephalon)
were dissected from each brain, and were stored at −80℃
until analysis took place. The telencephalon and diencepha-
lon were identified according to the brain atlas of the chick
(Kuenzel and Masson, 1988). Telencephalon collected is
part of the brain which excludes diencephalon and mesen-
cephalon. Diencephalon was divided by cutting between
stria medullaris and posterior commissure. Diencephalon
includes hypothalamus and thalamus. Monoamines (DA, 5-
HT) and their metabolites, homovanillic acid (HVA), 3,4-
dihydroxyphenylacetic acid (DOPAC) and 5-hydroxyin-
doleacetic acid (5-HIAA), were determined in these brain
regions as described elsewhere (Tomonaga et al., 2008), with
some modifications. The tissues were weighed and homo-
genized in a solution of 0.2M ice-cold perchloric acid con-
taining 0.01mM EDTA 2Na. Samples were allowed to sit
on ice for 30min for deproteinization. The homogenate was
centrifuged at 20,000 g for 15min. Supernatants were ad-
justed to pH 3 with 1M sodium acetate and were filtered
through a 0.2-μm filter (Millipore, Bedford, MA, USA). A
30-μl aliquot of filtrate was analyzed using a high-per-
formance liquid chromatography system (Eicom, Kyoto,
Japan) with a 150×3.0mm ODS column (SC-5ODS, Eicom)
and an electrochemical detector (ECD-300, Eicom) at an
applied potential of ＋750mV versus an Ag/AgCl reference
analytical electrode. The mobile phase was made up of an
aceto-citric acid buffer (pH 3.5, 0.1mol/l), methanol, sodium-
1-octane sulfonate (0.46mol/l) and disodium ethylenediami-
netetraacetic acid (0.01mol/l) (830:170:1.9:1). The external
standard containing 100 pg/μl of each MHPG, NE, DOPAC,
DA, 5HIAA, HVA and 5HT was used to identify peaks
eluting in the chromatogram relating to retention time and
conformation. The detection limit of the system for all
monoamines was 0.1 pg/sample.
Analysis of L- and D-Asp
L- and D-Asp contents in the plasma and brains were
analyzed according to the previously described method
(Ohmori et al., 2011). The supernatants that were collected
during the monoamine analysis were applied for the mea-
surement of L- and D-Asp contents in the brains. Plasma
was prepared by centrifuging it at 20,000×g for 15min at
4℃ (MX-307, Tommy, Japan), and then it was filtrated
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through ultrafiltration tubes (Millipore, Bedford, USA).
Each 20-μl sample of the brain or plasma was dissolved with
2 μl of 1M NaOH and then vortexed. Both the L- and the D-
Asp contents were measured by a UPLC (the Acquity
TM
UPLC system comprised of Waters Binary Solvent Manager,
Water Sample Manager and Waters FLR Detector) with an
ACCQ-TAG
TM
ULTRA C18 1.7 μm 2.1×100mm column
(Waters Corporation, USA). The excitation and emission
wavelengths for fluorescent detection of amino acids were
350 nm and 450 nm, respectively. The system was operated
with a flow rate of 0.25ml/min at 30℃. The UPLC gradient
system (A＝50mM sodium acetate (pH 5.9), B＝methanol)
was 10-20% B over 3.2min, 20% B for 1min, 20-40% B
over 3.6min, 40% B for 1.2min, 40-60% B over 3.8min,
60% B for 1min, and 60-10% B over 0.01min. Just before
the analysis in UPLC, each sample (10 μl) was transferred to
a UPLC tube, and N-acetylcysteine/O-phthalaldehyde (20 μl)
and a borate buffer (70 μl) were added; then it was left for 2
min in a dark room. The same method was used for the
standard solutions. The plasma amino acid concentrations
were expressed in nmol/ml, and the amino acid concentrations
in the brains were expressed as pmol/mg wet tissue.
Statistical Analysis
A repeated-measures two-way ANOVA was applied for
the analysis of food intake in both Experiments 1 and 2. For
the other parameters, a two-way ANOVA was applied. Sig-
nificant differences were denoted as p＜0.05. Values were
presented as means±S.E.M. Statistical analysis was made
using the commercially available package SAS (Version 9.0,
SAS Institute, Cary, U.S.A., 2002). All data in each group
were first subjected to a Thompson rejection test to eliminate
outliers (p＜0.01), and the remaining data were used for the
analysis among groups.
Results
Experiment 1: Effects of Oral Administration of L-Asp on
Food Intake, L- and D-Asp Contents in Plasma and the
Brain, and Monoamine Levels in the Brain of Chicks
Oral administration of several doses of L-Asp did not
significantly alter food intake in chicks (data not shown).
Table 1 shows the effect of oral administration of several
doses of L-Asp on the concentration of L- and D-Asp in
plasma and the brain. A significant (p＜0.007) positive cor-
relation was detected between the administered doses of L-
Asp and plasma concentration of L-Asp (−12.7[SE32.4]＋
34.0 [SE 11.6]X, R
2
＝0.235). However, administration of
L-Asp had no significant effect on the plasma concentration
of D-Asp. In the diencephalon, L- and D-Asp levels were
not significantly changed when different doses of L-Asp
were administered. In the telencephalon, significant effects
on the concentration of L- and D-Asp were detected with the
administration of L-Asp (F[3, 28]＝4.04, p＜0.05 for L-Asp
and F[3, 26]＝5.29, p＜0.01 for D-Asp), but there was not a
significant relationship between administered doses of L-
Asp and L-/D-Asp levels in the telencephalon.
Changes in monoamine content in the brain after oral
administration of L-Asp are shown in Table 2. DA in the
diencephalon was significantly (F [3, 27]＝3.23, p＜0.05)
changed, but no dose-dependent pattern was observed. No
other monoamines in either the diencephalon or the
telencephalon were significantly altered by oral L-Asp.
Experiment 2: Effects of Oral Administration of D-Asp on
Food Intake, L- and D-Asp Contents in Plasma and the
Brain, and Monoamine Levels in the Brain of Chicks
Fig. 1 shows the effects of oral administration of several
doses of D-Asp on food intake. There was a significant
effect of doses (F[3, 18]＝4.36, p＜0.05) and also a sig-
nificant (F[6, 36]= 2.45, p＜0.05) interaction between doses
and times. Food intake was reduced by oral administration
of D-Asp in a dose-dependent manner, and differences
among treatments were found to widen as time progressed.
Significant negative correlations were detected between the
administered doses of D-Asp and food intake at 30 (p＜
0.005, r＝0.594), 60 (p＜0.005, r＝0.572) and 120 (p＜
0.005, r＝0.581) min.
Table 3 shows changes in the contents of L- and D-Asp in
plasma, the diencephalon and the telencephalon after oral
administration of D-Asp. Significant increases in D-Asp
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48±5
a
Table 1. Effects of oral administration of several doses of L-Asp on plasma and
brain L- and D-Asp concentration in chicks
Plasma (nmol/ml)
L-Asp (mmol/kg body weight)
Means with different superscripts were significantly different at p＜0.05.
Values are means±S.E.M. The number of samples used for analysis ranged from 7 to 8.
D-Asp
2 .75±0 .47
2 ,673±3092 ,690±200L-Asp
15 .7±1 .520 .2±1 .9D-Asp
Telencephalon (pmol/mg wet tissue)
4 ,061±340
ab
3 ,126±200
b
L-Asp
38 .4±2 .6
a
32 .0±2 .1
ab
38 .7±1 .3
a
3 .25±0 .722 .40±0 .27D-Asp
Diencephalon (pmol/mg wet tissue)
4 ,273±150
a
146±47
a
16 .8±1 .1
2 ,349±234
38±3
b
L-Asp
26 .0±4 .0
b
3 ,300±367
ab
16 .9±2 .1
2 ,174±298
2 .92±0 .59
59±8
ab
157 .53 .750
levels were detected in plasma (F[3, 26]＝10.22, p＜0.0001)
and the diencephalon (F[3, 23]＝9.50, p＜0.001) in a dose-
dependent manner, but not in the telencephalon. No sig-
nificant changes in L-Asp levels were detected in plasma, or
in the diencephalon or telencephalon.
As shown in Table 4, monoamine contents in both the
diencephalon and the telencephalon were not altered by oral
D-Asp.
Discussion
The concept that L-Asp is a neurotransmitter in the CNS is
supported by a variety of data derived from studies involving
rats: L-Asp is not only concentrated in nerve endings
(Gundersen et al., 1991), but is also localized and found
accumulated in common synaptic vesicles (Gundersen et al.,
1998; Fleck et al., 2001). Thus, this study focused on the
effects of oral L-Asp and its enantiomer D-Asp on the food
intake in chicks as well as the controlling mechanism of this
behavior in the brain to clarify the physiological importance
of L- and D-Asp in birds.
It has been reported that there is a correlation between
orally administered doses of L-Asp and consequent concent-
rations of L-Asp in plasma in mice (Finkelstein et al., 1983;
Daabees et al., 1985). Thus, the effects of administered L-
Asp on plasma L-Asp levels were consistent between those
previously observed for mice and those observed for chicks
in Experiment 1. However, food intake did not decrease
significantly when chicks were orally administered L-Asp.
This result was consistent with the previous reports. Bungo
et al. (2002) reported that i.c.v. injection of L-Asp failed to
affect food intake at 30, 60 and 120min in Leghorn chicks.
Other supportive data are reported by Maruyama et al.
(1972), who demonstrated that a diet containing 6% L-Asp
did not lead to significantly decreased growth of chicks. In
the light of information mentioned above and of the results
from the present study, it might be suggested that central or
oral administration of L-Asp seemed to similar effects on
food intake in chicks.
In Experiment 2, oral administration of D-Asp reduced the
food consumption of chicks. Data from Experiment 2
indicate that oral administration of D-Asp caused in dose-
dependent decreases food intake at short-term (30, 60 or 120
min after oral administration). The oral administration
applied here seems to have a similar result with oral long-
term administration of D-Asp in rat (Koyuncuoğlu et al.,
1982). It is clear that D-Asp has an acute effect on decreases
in food intake.
It seems to be evident from the following reports that D-
Asp markedly reduces food consumption. First, Koyuncuoğlu
et al. (1982) revealed that orally administered D-Asp caused
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159±9
b
Table 2. Effects of oral administration of several doses of L-Asp on mono-
amine content in the diencephalon and telencephalon in chicks
Diencephalon (pg/mg wet tissue)
L-Asp (mmol/kg body weight)
Values are means±S.E.M. The number of samples used for analysis ranged from 7 to 8.
DA: dopamine, 5-HT: serotonin, and their metabolites, HVA: homovanillic acid,
DOPAC: 3,4-dihydroxyphenylacetic acid, and 5-HIAA: 5-hydroxyindoleacetic acid.
DOPAC
110±6138±16HVA
435±26394±235-HT
185±11189±135-HIAA
86±5
94±5
762±80759±685-HT
359±19440±525-HIAA
Telencephalon (pg/mg wet tissue)
391±63344±37DA
35 .4±3 .534 .4±1 .8
368±28
129±15
36 .5±3 .3
108±8109±7DOPAC
93±6101±11HVA
361±60
218±9
a
386±28
794±85
181±19
ab
DA
358±14
134±16
30 .4±1 .9
255±11
390±54
637±56
85±9
100±3
167±15
ab
202±19
157 .53 .750
186±16
Fig. 1. The effects of several doses of D-Asp on cumu-
lative food intake in chicks over a period of 2 h. The
number of chicks used in each group ranged between 4 and
7. Values are means with S.E.M.
significant decreases in body weight and in the weight of the
liver, as well as in daily food intake in rats. Second,
Sugahara et al. (1967) concluded that D-Asp has no nutri-
tional value and also has a retardation effect on chick growth.
Third, Maruyama et al. (1972) found that an amino acid diet
containing 2% D-Asp resulted in growth depression in
chicks. Finally, Koyuncuoğlu and Berkman (1982) revealed
that in rats, long-term oral administration of D-Asp caused a
significant decrease in daily food intake, total body weight,
and the weight of the liver and the kidneys; the concomitant
oral administration of L-Asp seemed to antagonize the effect
of D-Asp.
The reduced food intake following oral administration of
D-Asp could be explained by four possibilities mentioned
below. First, excessive D-Asp concentration may depress
the food intake of chicks through unbalanced proportions of
amino acids (Peng et al., 1969; Harper et al., 1970; Leung
and Rogers, 1971). Second, the reduced food intake might
be the result of the depressed peristaltic action of the di-
gestive tract that seemed to be caused by D-Asp administra-
tion (Maruyama et al., 1972). Notably, adverse effects of D-
Asp are greater in chicks fed a diet containing other D-amino
acids (Kamath and Berg, 1964; Marrett and Sunde, 1965).
Such effects are probably caused by a general interference in
the utilization of D-amino acids (Kamath and Berg, 1964;
Marrett and Sunde, 1965). Third, the concentration of D-
Asp in the diencephalon increased by 6.64 times compared
with the control (Table 3); although we do not know the
exact mechanism by which D-Asp decreased food intake in
proportion to the concentration of D-Asp in the brain, D-Asp
may act as a regulator of feeding since a major feeding
center, the hypothalamus, is present in the diencephalon.
Here, we propose the fourth possibility. It has been hy-
pothesized that opioid systems may be involved in the
regulation of food intake concerned with acquisition of
nutrients and in conservation and with expenditure of energy
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Table 3. Effects of oral administration of several doses of D-Asp on plasma and
brain L- and D-Asp concentration in chicks
Plasma (nmol/ml)
D-Asp (mmol/kg body weight)
Means with different superscripts were significantly different at p＜0.05.
Values are means±S.E.M. The number of samples used for analysis ranged from 5 to 8.
D-Asp
58±26
b
1 ,876±1521 ,920±90L-Asp
166±26
a
25±6
c
D-Asp
Telencephalon (pmol/mg wet tissue)
2 ,281±1575 ,081±1 ,672L-Asp
103±1490±37 83±29
2 ,146±490
a
8±2
b
D-Asp
Diencephalon (pmol/mg wet tissue)
5 ,723±2 ,157
7 .7±5 .2
47±8
bc
2 ,221±87
35 .7±8 .5L-Asp
99±50
4 ,789±1 ,705
112±25
ab
2 ,224±175
1 ,170±409
ab
25 .6±8 .9
157 .53 .750
470±68
Table 4. Effects of oral administration of several doses of D-Asp on mono-
amine content in the diencephalon and telencephalon in chicks
Diencephalon (pg/mg wet tissue)
D-Asp (mmol/kg body weight)
Values are means±S.E.M. The number of samples used for analysis ranged from 7 to 8.
DA: dopamine; 5-HT: serotonin; and their metabolites, HVA (homovanillic acid),
DOPAC (3,4-dihydroxyphenylacetic acid), and 5-HIAA (5-hydroxyindoleacetic acid).
DOPAC
99±3101±3HVA
486±17500±95-HT
162±5164±95-HIAA
72 .1±11 .1
51 .9±5 .5
486±24500±385-HT
263±21224±165-HIAA
Telencephalon (pg/mg wet tissue)
642±49573±46DA
39 .8±1 .339 .6±0 .7
537±11
95±3
37 .2±1 .6
47 .5±2 .144 .6±3 .1DOPAC
79 .8±7 .973 .2±4 .8HVA
552±64
387±37
241±19
537±47
449±33DA
536±13
92±5
39 .4±1 .2
590±29
273±18
536±15
77 .6±2 .5
53 .1±2 .3
496±61
160±7
157 .53 .750
146±9
(Margules, 1979). Although the endogenous opioid system
stimulated feeding behavior in mammals (Bodnar, 1996) and
birds (McCormarck and Denbow, 1988, 1989), several other
studies generally found in decreasing food intake (Kumar et
al., 1971; Frenk and Rogers, 1979; Marks-Kaufman and
Kanarck, 1980). The decrease in food intake can be ex-
plained not only by the direct effect of opioid, but also by the
opioid-induced release of antidiuretic hormone, arginine
vasopressin (AVP) (George and Way, 1959; Huidobro,
1978). In fact, AVP has long been known to be capable of
realizing adrenocorticotropic hormone (ACTH) (Gillis and
Lowry, 1979). Previous report revealed that the injection of
D-Asp released AVP in rat (Koyuncuoğlu et al., 1984).
In the light of information mentioned above, D-Asp causes
a decrease in food intake probably due to the increased levels
of AVP, endogeneous opioid and ACTH, respectively.
When both AVP and ACTH were taken into consideration
together with the actions of concomitantly released beta-
lipotropin and beta-endorphin, which may affect loss of
appetite being opioid, the body weight loss would be a quite
natural result in the rat (Koyuncuoğlu et al., 1984). Arginine
vasotocin (AVT), the avian homologue of mammalian AVP,
is also involved in the regulation of corticosterone release
mediated through the function of ACTH (Castro et al.,
1986). D-Asp may release AVT in the chicken as observed
in AVP by the mammal. In birds, there is limited in-
formation regarding the identification of opioid receptor
subtypes. It was reported that under conditions in which
birds had free access to food, DAMGO, a selective μ-opioid
receptor agonist, decreased food intake of chicks (Bungo et
al., 2004, 2005). Further experiment is necessary to clarify
the mechanism.
In our previous report, i.c.v. injection of L-Asp or D-Asp
clearly attenuated stress responses in chicks (Erwan et al.,
2012). In that study, both L- and D-Asp might directly act
on the center for stress responses located in the diencephalon.
On the other hand, in Experiment 1, L-Asp content in the
diencephalon was not increased by oral administration of L-
Asp, while in Experiment 2, D-Asp content was increased
after the oral administration of D-Asp. These differences
between L- and D-Asp could be explained by the specificity
of the mechanism of metabolism in D-Asp: the plasma D-
Asp concentration was elevated markedly (256-fold in the
highest D-Asp group compared with the control group) when
D-Asp was orally administrated, but the increase in plasma
L-Asp was limited when L-Asp was orally administered.
These findings strongly support previous research described
by Maruyama et al. (1972), who reported that free Asp
concentration in plasma was elevated markedly when the D-
Asp content of the diet was increased to 2 or 3%, whereas
values for chicks fed L-Asp did not change so much. The
accumulation of D-Asp in the plasma pool of chicks might
indicate that the capacity for oxidation of this amino acid is
limited. These results suggest that the metabolism of D-Asp
was very slow compared with that of L-Asp. Maruyama et
al. (1972) have proved that the removal of D-Asp from the
diet returns the plasma levels of Asp to normal in chicks. In
the present study, the methods applied were limited, since the
injection was done by gavage and narrow ranges of doses
were applied. Further conditions should be applied to clarify
the functions of L- and D-Asp in future.
When the focus was on monoamine levels in the brain,
significant changes were only minimally observed in both the
telencephalon and the diencephalon. In the present study,
NE was not detectable, but HVA as DA metabolite and 5HT
and 5HIAA were detected. These results may, at least in
part, reflect release of their respective neurotransmitters
(Gruss and Braun, 1997; Gruss et al., 1999). Focusing on
the variations in the basal values of DA content between the
experiments, several studies (Saito et al., 2004; Shiraishi et
al., 2010; Katayama et al., 2010, 2011; Erwan et al., 2012)
have reported the fluctuation of monoamine contents
especially in basal values of DA in the diencephalon or
telencephalon in chicks. The reason of these differences was
not clear. We conducted the same procedures when deter-
mined the monoamine contents. Due to these fluctuations
among studies, we compared the data within experiments but
not between experiments. However, to our knowledge there
is no report of relationships between the L- or D-Asp and
monoamines to explain the arousal effect of L- or D-Asp in
neonatal chick. These results confirmed those of our pre-
vious study (Erwan et al., 2012) in which monoamine levels
in the diencephalon and telencephalon were found not to be
modified by i.c.v. injection of L- or D-Asp in chicks. On the
other hand, several experiments have suggested that the
stimulation of NMDA receptors is linked to the regulation of
the monoaminergic system in the brain (Hanania and
Zahniser, 2002; Karlsson et al., 2006; Hamasu et al., 2009).
Thus, it remains unclear whether there is a relationship
between L- or D-Asp and the monoaminergic system, be-
cause monoamine levels in the brain do not always reflect the
activity of their neurons. Furthermore, we only measured
monoamine contents in the present study, and not mono-
amine release, which may be a more precise marker of
monoamine neuronal activity. Further work focusing on the
relationship between Asp and the monoaminergic system in
the brain is necessary.
In conclusion, orally administered D-Asp, but not orally
administered L-Asp, had a negative, depressive effect on
food intake in neonatal chicks. D-Asp may control the
feeding center without producing changes in the metabolism
of monoamines.
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